CJC-1295 (also known as Modified GRF 1-29, DAC:GRF) is a growth-hormone-releasing hormone analog studied for GH support. This page covers what the published research does — and does not — establish about it in relation to growth-hormone support.
CJC-1295 is researched for Growth hormone release — which is why it appears in discussions of growth-hormone support.
Research status: Some human pharmacology studies; not an approved therapy.
How CJC-1295 is thought to work
CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH). It stimulates the pituitary to release the body's own growth hormone in a more sustained way, and is often researched together with a ghrelin-type secretagogue for a more pulsatile release pattern.
What it does not establish
Affects the endocrine system. Research use only in most regions.
Nothing on this page is a recommendation to use CJC-1295, and Selpho publishes no dosing, reconstitution or sourcing information. Read how we decide what goes in the library.
Commonly researched alongside
A selective growth-hormone secretagogue studied for its clean GH-release profile.
Other peptides researched for Growth Hormone
A selective growth-hormone secretagogue studied for its clean GH-release profile.
One of the earliest GHRH analogs, historically used to assess GH function.
A GHRH analog approved for HIV-associated lipodystrophy and studied for visceral fat.
An early GH-releasing peptide known for strongly stimulating appetite.
A potent GH secretagogue also studied for cardiac tissue effects.
An orally active growth-hormone secretagogue (a non-peptide) studied for GH/IGF-1.
Frequently asked questions
Some human pharmacology studies; not an approved therapy. Research relevant to this area covers growth hormone release. That is a description of where the research points, not evidence that it will work for you — and Selpho does not provide dosing or medical advice.
Some human pharmacology studies; not an approved therapy.
Affects the endocrine system. Research use only in most regions. Always speak to a licensed healthcare professional before considering any peptide.
Increasing the body's own growth-hormone output, with downstream interest in body composition, recovery, and sleep.
No. Rather than supplying growth hormone directly, it prompts your pituitary to release more of its own. It affects the endocrine system and is research-use in most regions.
Is CJC-1295 right for your situation?
Describe your goals and the free Peptide Advisor will match them against the research — no signup, no sales pitch.
Ask the Advisor — freeThis page is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.